IGKV1D-22 and inflammatory bowel disease: Notably, quercetin—a flavonoid that exhibits its nicotinergic activity through α3, α7, and α9 nAChRs [61–64]—produces an anti-inflammatory effect and ameliorates experimental IBD [65, 66].